BRIEF published on 09/22/2025 at 08:35, 2 months 12 days ago SpineGuard obtains European validation for its patent in orthopedic surgery Orthopedic Surgery European Patent SpineGuard DSG Technology Medical Algorithms
PRESS RELEASE published on 09/22/2025 at 08:30, 2 months 12 days ago Inside Information / Other news releases SpineGuard receives European patent for bone breach detection in orthopedic drills & robots, enhancing tool safety w/ DSG tech. Expands IP portfolio & strategic industry collaborations European Patent SpineGuard DSG Technology Bone Breach Detection Orthopedic Drills
BRIEF published on 05/05/2025 at 12:43, 6 months 30 days ago SpineGuard Announces Combined General Meeting for June 2025 Shareholder Vote General Assembly Votaccess SpineGuard Paris 2025
BRIEF published on 01/03/2025 at 18:41, 11 months 1 day ago SpineGuard Reveals 2025 Financial Calendar Financial Calendar Sales Results Shareholders Meeting SpineGuard DSG Technology
PRESS RELEASE published on 01/03/2025 at 18:36, 11 months 1 day ago Inside Information / Other news releases SpineGuard announces its 2025 financial calendar and schedule for the publication of financial information, including sales and results dates Financial Information SpineGuard DSG Technology 2025 Financial Calendar Bone Implants
BRIEF published on 09/30/2024 at 19:38, 1 year 2 months ago SpineGuard Secures FDA Clearance for New PsiFGuard Device FDA Clearance SpineGuard DSG Technology PsiFGuard SI Joint Fusion
PRESS RELEASE published on 09/30/2024 at 19:33, 1 year 2 months ago Inside Information / Other news releases SpineGuard receives FDA clearance for PsiFGuard smart drilling device dedicated to sacroiliac joint fusion, expanding DSG technology in the US FDA Clearance Sacroiliac Joint Fusion SpineGuard DSG Technology PsiFGuard
BRIEF published on 07/08/2024 at 15:28, 1 year 4 months ago SpineGuard closes a capital increase of 1.13 million euros Subscription Increase In Capital New Actions SpineGuard DSG Technology
Published on 12/05/2025 at 02:35, 2 hours ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 35 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 30 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 35 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 4 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 44 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 9 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 20 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 24 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 35 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 50 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 50 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 34 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
